scholarly journals Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage

Hepatology ◽  
1999 ◽  
Vol 29 (1) ◽  
pp. 27-32 ◽  
Author(s):  
Luis García-Villarreal ◽  
Francisco Martínez-Lagares ◽  
Angel Sierra ◽  
Clemencia Guevara ◽  
José M. Marrero ◽  
...  
Author(s):  
Benjamin J. McCafferty ◽  
Husamedin El Khudari ◽  
Aliaksei Salei ◽  
Andrew J. Gunn

AbstractVariceal hemorrhage is a morbid condition that frequently mandates the involvement of interventional radiology to achieve successful and sustained hemostasis. Primary image-guided therapies for variceal hemorrhage include a transjugular intrahepatic portosystemic shunt and transvenous obliteration. Knowledge of variceal pathophysiology and anatomy, current techniques, and the evidence supporting therapeutic selection is paramount to successful patient outcomes. The purpose of this review is to provide the reader a framework of the available literature on image-guided management of bleeding varices to assist in clinical management.


Author(s):  
Zubin Irani ◽  
Sara Zhao

Transjugular intrahepatic portosystemic shunt (TIPS) was first described by Rosch et al. in 1969, and in 1982, Colopinto et al. described its first clinical application in a patient with cirrhosis and variceal hemorrhage. It was not until 1988 that the first metal-lined shunt was created, and in 1997 the first polytetrafluoroethylene (PTFE)-lined stent was used in humans for shunt revision after stenosis, created by pinning the Gore PTFE graft material between two metal stents. Introduced in 2000, the Viatorr stent graft is now the most commonly used device for TIPS. One of the major side effects of TIPS creation is hepatic encephalopathy (HE). This chapter discusses the adjustable small-diameter transjugular intrahepatic portosystemic shunt.


Sign in / Sign up

Export Citation Format

Share Document